Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corbus Pharmaceuticals

8.83
-0.3400-3.71%
Post-market: 8.80-0.0300-0.34%19:00 EDT
Volume:98.22K
Turnover:876.50K
Market Cap:108.05M
PE:-2.09
High:9.16
Open:8.98
Low:8.80
Close:9.17
Loading ...
May 19, 2025

Major Issues Report

Form 8-K - Current report
May 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Major Issues Report

Form 8-K - Current report
Mar 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Mar 11, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2025

Major Issues Report

Form 8-K - Current report
Feb 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]